APR 01, 2020 6:01 AM PDT

One dollar kit diagnoses COVID-19 in 10 minutes

WRITTEN BY: Tara Fernandez

 

Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 infection in just 10 minutes. In the absence of approved COVID-19 vaccines or antiviral therapies, a cost-effective and widely-available diagnostic kit is the best bet for flattening the curve, particularly in cities about to be hit hard by the ongoing pandemic.

Once the diagnostics are found to meet stringent regulatory standards, the kit’s creators plan to mass-produce the tests in Senegal and United Kingdom. They are projected to be available for distribution in Africa as early as June.

The test’s developers will sell the kits at the cost price of just $1, a feat made possible with funding support from both the UK government and the Bill and Melinda Gates Foundation.

Slowing the spread of the contagion by allowing public healthcare systems to test populations for COVID-19 quickly and accurately has been among the most pressing priorities for many cities in the throes of a pandemic. Rural communities lacking access to specialized diagnostic laboratories will face even bigger challenges should an outbreak occur in their area.

 

 

The newly developed coronavirus test aims to address this issue by allowing an individual to test for the virus with either a saliva sample or finger prick, all from the comfort of home. The saliva swab method is appropriate for those suspected of having an active infection and works by detecting the presence of viral particles. The blood test would help post-symptomatic individuals to confirm their COVID-19 infection and reduce the risk to their families by checking for circulating antibodies against SARS-CoV-2.

Experts warn that a surge in cases could completely overwhelm health systems in developing countries, a situation that will only be exacerbated by sanitation issues and food supply shortages. The hope is that developments in diagnostic technology such as this will help abate potential outbreaks across the globe and provide a durable solution for what is shaping up to be a long-term problem.

 


Source: Al Jazeera.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 26, 2019
Cannabis Sciences
NOV 26, 2019
Cannabis Provides Relief from Headache and Migraine Pain
Innovative technology allowed researchers to conduct the first-ever study of cannabis use for the treatment of headache ...
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. B ...
DEC 28, 2019
Microbiology
DEC 28, 2019
A DNA Star That Can Detect Dengue Virus
Like origami paper, DNA molecules can be folded and arranged into complex three-dimensional structures.
MAR 02, 2020
Clinical & Molecular DX
MAR 02, 2020
Bluetooth-enabled skin patch monitors diabetics' glucose levels
A new wearable skin patch could completely transform daily glucose tracking routines for diabetics. This innovation, dev ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
Loading Comments...